SARAH SCOLPINI: Open Payments
NPI 1417739665 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 11 companies in 2025. Trend: 2023 $41 · 2024 $1,356 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $50 |
| Sequel Med Tech, LLC | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $19 |
| BETA BIONICS, INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| KYOWA KIRIN, INC. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
Products named: TEPEZZA, TWIIST, CRENESSITY, MINIMED 780G, EVENITY, iLet Bionic Pancreas, Ozempic, GVOKE HYPOPEN.
Industry payments across CT — which companies pay providers there.
